NEDA as a predictor of conversion to secondary progressive multiple sclerosis in patients with relapsing-remitting multiple sclerosis

被引：0

作者：

Kappos, L. ^{[1
,2
,3
,4
]}

Stefano, N. D. ^{[5
]}

Sormani, M. P. ^{[6
]}

Giovannoni, G. ^{[7
]}

Haring, D. ^{[8
]}

Tomic, D. ^{[8
]}

Meier, D. Piani ^{[8
]}

Chitnis, T. ^{[9
]}

机构：

[1] Univ Basel Hosp, Neurol Clin & Policlin, Dept Med, Basel, Switzerland

[2] Univ Basel Hosp, Neurol Clin & Policlin, Dept Clin Res, Basel, Switzerland

[3] Univ Basel Hosp, Neurol Clin & Policlin, Dept Biomed, Basel, Switzerland

[4] Univ Basel Hosp, Neurol Clin & Policlin, Dept Biomed Engn, Basel, Switzerland

[5] Univ Siena, Siena, Italy

[6] Univ Genoa, Dept Hlth Sci, Biostat Unit, Genoa, Italy

[7] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England

[8] Novartis Pharma AG, Basel, Switzerland

[9] Massachusetts Gen Hosp, Partners Pediat Multiple Sclerosis Ctr, Boston, MA 02114 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P1217

引用

页码：638 / 639

页数：2